These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. Elias M; Heethuis A; Weggemans M; Bom V; Blom N; McShine RL; Halie MR; Smit Sibinga CT Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080 [TBL] [Abstract][Full Text] [Related]
23. The effects of heparin bound surface modification (Carmeda Bioactive Surface) on human platelet alterations during simulated extracorporeal circulation. Stenach N; Korn RL; Fisher CA; Jeevanandam V; Addonizio VP J Extra Corpor Technol; 1992; 24(3):97-102. PubMed ID: 10148074 [TBL] [Abstract][Full Text] [Related]
24. Effects of iloprost on salt-sensitive Dahl rats. Somova L Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):443-7. PubMed ID: 8577205 [TBL] [Abstract][Full Text] [Related]
29. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation. Addonizio VP; Macarak J; Nicolaou KC; Edmunds LH; Colman RW Blood; 1979 Jun; 53(6):1033-42. PubMed ID: 375998 [No Abstract] [Full Text] [Related]
30. Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. Grauso F; Biagi G; Puddu P; Bugiardini R; Capelli M; Coccheri S Thromb Res; 1987 Oct; 48(2):131-43. PubMed ID: 2447664 [TBL] [Abstract][Full Text] [Related]
34. Platelet involvement in the activated coagulation time of heparinized blood. Moorehead MT; Westengard JC; Bull BS Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544 [TBL] [Abstract][Full Text] [Related]
35. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383 [TBL] [Abstract][Full Text] [Related]
36. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation. Hiramatsu Y; Homma S; Sato Y; Sato S; Matsuzaki K; Shigeta O; Sakakibara Y Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071 [TBL] [Abstract][Full Text] [Related]
37. [Thrombocyte functional activity and ultrastructure during artificial circulation with membrane oxygenation of the blood]. Beliakov NA; Vashkinel' VK; Zhuravleva IN; Simbirtsev SA; Petrash VV Anesteziol Reanimatol; 1980; (6):26-9. PubMed ID: 7212359 [No Abstract] [Full Text] [Related]
38. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [TBL] [Abstract][Full Text] [Related]
39. Intraoperative management of patients with heparin-induced thrombocytopenia. Kappa JR; Fisher CA; Todd B; Stenach N; Bell P; Campbell F; Ellison N; Addonizio VP Ann Thorac Surg; 1990 May; 49(5):714-22; discussion 723. PubMed ID: 1692679 [TBL] [Abstract][Full Text] [Related]
40. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]